Levodopa/carbidopa intestinal gel infusion and weight loss in Parkinson's disease

Background and purpose Weight loss (WL) is a frequent yet under‐recognized complication of levodopa/carbidopa intestinal gel (LCIG) infusion, as well as a milestone of Parkinson's disease (PD) disability progression. The complex association between WL, poor nutritional status, motor complicatio...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European journal of neurology 2019-03, Vol.26 (3), p.490-496
Hauptverfasser:	Fabbri, M., Zibetti, M., Beccaria, L., Merola, A., Romagnolo, A., Montanaro, E., Ferreira, J. J., Palermo, S., Lopiano, L.
Format:	Artikel
Sprache:	eng
Schlagworte:	Activities of daily living Cognitive ability Complications Correlation Dementia disorders disease progression Dyskinesia Dysphagia Feeding Intestine Levodopa levodopa/carbidopa intestinal gel malnutrition Mental depression Motors Movement disorders Neurodegenerative diseases Nutritional status Parkinson's disease Patients Signs and symptoms Weight loss
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!